Effect of a synthetic immunomodulator on the regulation of gamma interferon and interleukin-10 production during salmonella sepsis in ity(s) mice

International Journal of Immunopathology and Pharmacology

Volumn 10, Issue 3, 1997, Pages 167-174

  Ferlat, S ^a   Bottex Gauthier, C ^a   Li, M ^b   Picot, F ^b   Vidal, D ^a   Potier, P ^b  

^a CENTRE DE RECHERCHES   (France)

^b CNRS   (France)

Author keywords

10 HDA derivative; Cytokine balance; Gram negative sepsis; Immunomodulation

Indexed keywords

1 (2 METHOXYETHOXYMETHYL) 2,3 (10 HYDROXY 2 DECENOYL)GLYCEROL; 10 HYDROXY 2 DECENOIC ACID; CYTOKINE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; INTERLEUKIN 10; ROYAL JELLY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; GRAM NEGATIVE INFECTION; IMMUNOMODULATION; INFECTION RESISTANCE; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE FUNCTION; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SEPSIS; SPLEEN CELL;

EID: 0031473761     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463209701000301     Document Type: Article

References (47)

1. s mice. J. Med. Microbiol. 42:348.
2. Arai T., K. Hiromatsu, H. Nishimura, Y. Kimura, N. Kobayashi, H. Ishida, Y. Nimura and Y. Yoshikai. 1995. Effects of in vivo administration of anti-IL-10 monoclonal antibody on the host defence mechanism against murine Salmonella infection. Immunology 85:381.
3. Wherry J.C., R.D. Schreiber and E.R. Unanue. 1991. Regulation of Gamma Interferon production by natural killer cells in scid mice : role of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59:1709.
4. Nauciel C. and F. Espinasse-Maes. 1992. Role of gamma Interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect. Immun. 60:450.
5. Saito S., K. Onozuka, H. Shinomiya and M. Nakano. 1991. Sensitivity of bacteria to NaNO2 and to L-arginine-dependent system in murine macrophages. Microbiol. Immunol. 35:325.
6. Yang J., I. Kawamura, H. Zhu and M. Mitsuyama. 1995. Involvement of natural killer cells in nitric oxide production by spleen cells after stimulation with Mycobacterium bovis BCG. J. Immunol. 155:5728.
7. Al-Ramadi B.K., Y.W. Chen, J.J. Meissler, Jr. and T.K. Eisenstein. 1991. Immunosuppression induced by attenuated Salmonella. Reversal by IL-4. J. Immunol. 147:1954.
8. Mills C.D. 1991. Molecular basis of «suppressor» macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146:2719.
9. Augusto O., E. Linares and S. Giorgio. 1996. Possible roles of nitric oxide and peroxynitrite in murine leishmaniasis. Brazil. J. Med. Biol. Res. 29:853.
10. Marcinkiewicz J. and B.M. Chain. 1993. Differential regulation of cytokine production by nitric oxide. Immunology 80:146.
11. Gérard C., C. Bruyns, A. Marchant, D. Abramovicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
12. Howard M., T. Muchamuel, S. Andrade and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
13. Bodgan C., Y. Vodovotz and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549.
14. Fiorentino D.F.,A. Zlotnik, T.R. Mosmann, M. Howard and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
15. Howard M.A., A. O'Garra, H. Ishida, R. de Waal Malefyt and J. de Vries. 1992. Biological properties of interleukin 10. J. Clin. Immunol. 12:239.
16. Stevens G. 1993. Immunomodulating drugs: whence and whither. Immunomodulating drugs. V. St Georgiev, H. Yamaguchi, ed. Ann. NY Acad. Sci. N.Y., p. 9430.
17. Butenandt A. and H. Rembold. 1957. Uber den Weiselzellenfuttersaft der Honigniene. I. Isolierung, Konstitutionsermittlung und Vorkommen der 10-Hydroxy-2-decensaûre. Hoppe-Seyl. Z. 308:284.
18. Tamura T., A. Fujji and N. Kuboyama. 1987. Antitumor effects of royal jelly (RJ). Folia Pharmac. Jap. 89:73.
19. Bottex C., S. Ferlat, F. Condemine, N. Burdin, D. Vidal, F. Picot, and P. Potier. 1995. Modulation of TNF-a and NO responses in S. typhimurium infected mice after in vivo immunomodulatory therapy. In The Biology of Nitric Oxide Part 5. S. Moncada, J. Sammler, S. Gross, and E. A. Higgs, ed. Portland Press London, p.149.
20. Freudenberg M.A., Y. Kumazawa, S. Meding, J. Langhorne and C. Galanos. 1991. Gamma interferon production in endotoxin-responder and non-responder mice during infection. Infect. Immun. 59:3484.
21. Ding A.H., C.F. Nathan and D.J. Stuehr. 1988. Release of reactive nitrogen intermediates from mouse peritoneal macrophages : comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
22. Sver L., N. Orsolic, Z. Tadic, B. Njari, I. Valpotic and I. Basic. 1996. A royal jelly as a new potential immunomodulator in rats and mice. Comp. Immun. Microbiol. Infect. Dis. 19:31.
23. Langlade H., H. Hinglais and M. Hinglais. 1957. Bactericidal activity of royal jelly on the tuberculosis bacillus. Ann. Inst. Pasteur 93:272.
24. Fujiwara S., J. Imai, M. Fujiwara, T. Yaeshima, T. Kawashima and K. Kobayashi. 1990. A potent antibacterial protein in royal jelly. Purification and determination of the primary structure of royalisin. J. Biol. Chem. 256:11333.
25. Bonvehi J.S. and R.E. Jorda. 1991. Organic acids influence on microbiological quality and bacteriostatic activity of royal jelly. Dt. Lebensm. Rdsch. 87:256.
26. Stejskal M. 1961. Preliminary report on the killing of Trypanosoma cruzi Chagas by royal jelly. Bee World 42:231.
27. Wu G., T.M.E. Liu and K.K. Ho. 1992. Growth inhibition of Ascosphaera apis by royal jelly and 10-hydroxy-2-decenoic acid. Bull. Inst. Zool. Acad. Sin. (Taipei) 31:73.
28. Buchmuller-Rouiller Y. and J. Mauel. 1986. Correlation between enhanced oxidative metabolism and leishmanicidal activity in activated macrophages from healer and non healer mouse strain. J. Immunol. 136:3884.
29. Adams D.O. and T.H. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:283.
30. Benjamin, W.H. Jr., P. Hall, S.J. Roberts, and D.E. Briles. 1990. The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing. J. Immunol. 144:3143.
31. Lissner C.R., R.N. Swanson and A.D. O'Brien. 1993. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J. Immunol. 131:3006.
32. Van Dissel J.T., J.J.M. Stikkelbroeck, M.T. Van den Barselaar, W. Sluiter, P.C. Leijh and R. Van Furth. 1987. Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages. J. Immunol. 139:1665.
33. Green, S.J., L.F. Scheller, M.A. Marletta, M.C. Seguin, F.W. Klotz, M. Slayter, B.J. Nelson and C.A. Nacy. 1994. Nitric oxide : cytokine-regulation of nitric oxide in host resistance to intracellular pathogens. Immunol. Letters 43:87.
34. Beckerman K.P., H.W. Rogers, J.A. Corbett, R.D. Schreiber, M.L. McDaniel and E. Unanue. 1993. Release of nitric oxide during the T cell-independent pathway of macrophage activation. J. Immunol. 150:888.
35. r) mice to lipopolysaccharide administration and Salmonella typhimurium infection. Infect. Immun. 60:1375.
36. Edwards III C.K., S.M. Ghiasuddin, L.M. Yunger, R.M. Lorence, S. Arkins, R. Dantzer and K.W. Kelley. 1992. In vivo administration of recombinant growth hormone or gamma interferon activates macrophages : enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates. Infect. Immun. 60:2514.
37. Muotiala A. and P.H. Mäkela. 1990. The role of IFN-g in murine Salmonella typhimurium infection. Microb. Pathog. 8:135.
38. Muotiala A. and P.H. Mäkela. 1993. Role of gamma interferon in late stages of murine Salmonellosis. Infect. Immun. 61:4248.
39. Benbernou N. and C. Nauciel. 1994. Influence of mouse genotype and bacterial virulence in the generation of interferon-g-producing cells during the early phase of Salmonella typhimurium infection. Immunology 83:245.
40. Ramarathinam L., D.W. Niesel and G.R. Klimpel. 1993. Salmonella typhimurium induces IFN-g production in murine splenocytes. J. Immunol. 150:3973.
41. Ramarathinam L., D.W. Niesel and G.R. Klimpel. 1993. Ity influences the production of IFN-g by murine splenocytes stimulated in vitro with Salmonella typhimurium. J. Immunol. 150:3965.
42. Kohler J., D. Heumann, G. Garotta, D. Leroy, S. Bailat, C. Barras, J.D. Baumgartner and M.P. Glauser. 1993. IFN-g involvement in the severity of Gram-negative infections in mice. J. Immunol. 151:916.
43. Tormey V.J., J. Faul, C. Leonard, C.M. Burke, A. Dilmec and L.W. Poulter. 1997. T-cell cytokines may control the balance of functionally distinct macrophage populations. Immunology 90:463.
44. Ayala A. and I.H. Chaudry. 1996. Immune dysfunction in murine polymicrobial sepsis : mediators, macrophages, lymphocytes and apoptosis. Shock 6:527.
45. Unanue, E.R. 1997. Inter-relationship among macro-phages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr. Opin. Immunol. 9:35.
46. Trinchieri, G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-g). Curr. Opin. Immunol. 9:17.
47. Walley K.R., N.W. Lukacs, T.J. Standiford, R.M. Strieter and S.L. Kunkel. 1996. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect. Immun. 64:4733